Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joseph Truitt currently holds 55,150 shares of Larimar Therapeutics, Inc. (LRMR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Truitt has been a net seller of LRMR stock. They have purchased $24.5K and sold $1.6M worth of shares.
Joseph Truitt's most recent insider trade was on May 19, 2026, when they sold 55,150 shares at $0.00 per share.
Joseph Truitt serves as Executive at Larimar Therapeutics, Inc. (LRMR). They have executed 17 insider transactions totaling $1.6M over their tenure at the company.
Joseph Truitt holds the position of Executive at Larimar Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Joseph Truitt has shown a selling trading pattern, with $24.5K in total purchases and $1.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joseph Truitt was on Oct 16, 2019, when they sold $638.5K worth of ACHN shares. This transaction involved 100,234 shares at $6.37 per share.
Joseph Truitt currently owns 55,150 shares of Larimar Therapeutics, Inc. (LRMR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joseph Truitt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joseph Truitt has 17 Form 4 filings on record as an insider at Larimar Therapeutics, Inc..
Set alerts for Joseph Truitt and 40,000+ other insiders.